Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury

Launched by UNIVERSIDAD REY JUAN CARLOS · Feb 28, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring whether using the Nintendo Switch video game console, alongside traditional therapy, can help adults with acquired brain injuries. The goal is to see if playing interactive games can make therapy more enjoyable, boost motivation, and improve physical and mental abilities, such as balance and cognitive function. Participants in the study will be divided into two groups: one will use the Nintendo Switch for up to eight weeks, while the other will continue with their usual therapy.

To be eligible for this trial, participants need to be over 30 years old and have experienced an acquired brain injury. They should also have mild to moderate cognitive impairment but be capable of participating in therapy sessions. Those who join the study can expect to take part in either the experimental group, which involves playing games, or the control group, which will stick to standard therapy. It's important to know that this trial is currently recruiting participants and aims to enhance the overall satisfaction and effectiveness of rehabilitation for individuals recovering from brain injuries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult men and women, over 30 years of age who have suffered an acquired brain injury.
• • Mild or moderate cognitive impairment as measured by the MEC-Lobo test (score greater than 23/35).
• • Regularly attend some conventional therapy (neuropsychology, physiotherapy or occupational therapy).
• • Agree to participate voluntarily by signing the informed consent form.
• Exclusion Criteria:
• • Present severe cognitive impairment as measured by the MEC-Lobo test (less than 23/35).
• • Present aphasia of comprehension or expression.
• • Present associated neurodegenerative pathology.
• • Present any pathology underlying the acquired brain damage (diabetes, heart disease, COPD, etc.), heart disease, COPD, etc.).
• • Voluntarily refuse to participate in the study.